Osaic Holdings’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Osaic Holdings’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,920	Closed	-$1.73M	–	7646
2023 Q3	$1.73M	Sell	14,920 -9,701	-39%	-$1.04M	﹤0.01%	2135
2023 Q2	$2.53M	Sell	24,621 -24,080	-49%	-$2.54M	﹤0.01%	1673
2023 Q1	$5.32M	Sell	48,701 -16,861	-26%	-$1.86M	0.01%	1115
2022 Q4	$7.46M	Buy	65,562 +21,725	+50%	+$1.8M	0.02%	871
2022 Q3	$2.71M	Buy	43,837 +1,737	+4%	+$121K	0.01%	1416
2022 Q2	$3.36M	Buy	42,100 +11,123	+36%	+$1.05M	0.01%	1296
2022 Q1	$3.07M	Sell	30,977 -14,499	-32%	-$1.41M	0.01%	1575
2021 Q4	$4.9M	Buy	45,476 +11,156	+33%	+$1.22M	0.01%	1123
2021 Q3	$3.76M	Buy	34,320 +905	+3%	+$94K	0.01%	1231
2021 Q2	$3.14M	Buy	33,415 +1,900	+6%	+$175K	0.01%	1350
2021 Q1	$2.9M	Buy	31,515 +5,846	+23%	+$493K	0.01%	1306
2020 Q4	$1.88M	Sell	25,669 -21,697	-46%	-$1.61M	0.01%	1498
2020 Q3	$3.68M	Buy	47,366 +14,019	+42%	+$965K	0.01%	927
2020 Q2	$1.85M	Buy	33,347 +1,992	+6%	+$85.2K	0.01%	1296
2020 Q1	$683K	Buy	+31,355	New	+$1.06M	﹤0.01%	1823

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Osaic Holdings's HZNP Position: Q4 2023 in Review

Osaic Holdings sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 14,920 shares — an estimated $1.73M sold.

Osaic Holdings first reported a position in HZNP in Q1 2020 and held it in 15 quarters. The position peaked at $7.46M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Osaic Holdings reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Osaic Holdings sold 14,920 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.73M.
Osaic Holdings first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2020 and held it in 15 quarters.
Osaic Holdings's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $7.46M in Q4 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.